7151 - 7160 of 8606 Results
Title
Year
-
OPENTitle: A pipeline for RNA-seq based eQTL analysis with automated quality control proceduresJournal Name: BMC BioinformaticsPublisher: Springer Science and Business Media LLCVol: 22Issue #: S9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12859-021-04307-0Best OA location URL: https://bmcbioinformatics.biomedcentral.com/track/pdf/10.1186/s12859-021-04307-0Citation Count: 38
- Prevalence and characteristics of the aberrant anterior tibial artery: a single-center magnetic resonance imaging study and scoping review2021OPENTitle: Prevalence and characteristics of the aberrant anterior tibial artery: a single-center magnetic resonance imaging study and scoping reviewJournal Name: BMC Musculoskeletal DisordersPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12891-021-04801-9Best OA location URL: https://bmcmusculoskeletdisord.biomedcentral.com/track/pdf/10.1186/s12891-021-04801-9Citation Count: 5
- Rationale and design to evaluate the PRIME Parkinson care model: a prospective observational evaluation of proactive, integrated and patient-centred Parkinson care in The Netherlands (PRIME-NL)2021OPENTitle: Rationale and design to evaluate the PRIME Parkinson care model: a prospective observational evaluation of proactive, integrated and patient-centred Parkinson care in The Netherlands (PRIME-NL)Journal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-021-02308-3Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-021-02308-3Citation Count: 33
-
OPENTitle: Posterior Cortical Atrophy phenotype in a GBA N370S mutation carrier: a case reportJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-020-02023-5Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-020-02023-5Citation Count: 6
- Low continuation of antipsychotic therapy in Parkinson disease – intolerance, ineffectiveness, or inertia?2021OPENTitle: Low continuation of antipsychotic therapy in Parkinson disease – intolerance, ineffectiveness, or inertia?Journal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-021-02265-xBest OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-021-02265-xCitation Count: 15
- Real-world assessment of the impact of “OFF” episodes on health-related quality of life among patients with Parkinson’s disease in the United States2021OPENTitle: Real-world assessment of the impact of “OFF” episodes on health-related quality of life among patients with Parkinson’s disease in the United StatesJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-021-02074-2Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-021-02074-2Citation Count: 18
- Longitudinal observational study of boxing therapy in Parkinson’s disease, including adverse impacts of the COVID-19 lockdown2021OPENTitle: Longitudinal observational study of boxing therapy in Parkinson’s disease, including adverse impacts of the COVID-19 lockdownJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-021-02359-6Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-021-02359-6Citation Count: 11
-
RESTRICTEDTitle: Disrupted rich-club organization of brain structural networks in Parkinson’s diseaseJournal Name: Brain Structure and FunctionPublisher: Springer Science and Business Media LLCVol: 226Issue #: 7Start Page: 2205End Page: 2217Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00429-021-02319-3Citation Count: 19
-
OPENTitle: TP53INP1 exerts neuroprotection under ageing and Parkinson’s disease-related stress conditionJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 12Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-021-03742-4Best OA location URL: https://www.nature.com/articles/s41419-021-03742-4.pdfCitation Count: 17
- Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies2021OPENTitle: Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III StudiesJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 7Start Page: 781End Page: 794Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-021-00826-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-021-00826-9.pdfCitation Count: 15